News

Oct 20, 2024 | BALTIMORE – Complete Omics Inc., a trailblazer in clinical proteomics and multi-omics molecular diagnostics, is proud to announce its recent achievement of CLIA and CAP certifications, along with enrollment in the Medicare system. These accomplishments underscore Complete Omics’ unwavering commitment to providing top-tier diagnostic solutions, grounded in excellence and reliability, and advancing patient care through accessible, state-of-the-art clinical proteomics testing services.

The CLIA (Clinical Laboratory Improvement Amendments) certification sets a federally mandated standard for laboratory quality, accuracy, and compliance. Achieving this certification confirms Complete Omics’ ability to deliver consistent, high-quality diagnostic results that healthcare providers and patients can trust.

Adding to this achievement, the CAP (College of American Pathologists) certification is another hallmark of Complete Omics’ dedication to excellence. Recognized as the gold standard in laboratory quality assurance, CAP certification involves rigorous inspections and assessments, ensuring that our laboratory adheres to the highest standards in pathology and laboratory medicine. Together, these certifications validate our ongoing commitment to clinical integrity, reliability, and patient safety.

Enrollment in the Medicare system further broadens access to Complete Omics’ advanced diagnostics, making our cutting-edge proteomics-based testing solutions available to Medicare beneficiaries. With this inclusion, Complete Omics is poised to bring critical insights for early disease detection and personalized treatment to a larger population, reinforcing its mission to make precision diagnostics a standard in modern healthcare.

“Our CLIA and CAP certifications, along with Medicare enrollment, mark significant milestones for Complete Omics as we expand our reach and impact in the clinical diagnostics field,” said Qing Wang, Founder and CEO of Complete Omics Inc. “We are dedicated to providing healthcare professionals and patients with reliable, high-quality diagnostic services that empower precise healthcare decisions and foster improved patient outcomes.”

Complete Omics Inc. remains committed to innovation and quality in clinical proteomics and multi-omics blood tests, setting new benchmarks in diagnostic technology and accessibility.